Neuroendocrine Differentiation in Metastatic Prostatic Adenocarcinoma-Reference-Cited by-同舟云学术

Neuroendocrine Differentiation in Metastatic Prostatic Adenocarcinoma

Published:1994-04 Issue:4 Volume:151 Page:914-919
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Aprikian Armen G.¹,Cordon-Cardo Carlos¹,Fair William R.¹,Zhang Zuo-Feng¹,Bazinet Michel¹,Hamdy Seif M.¹,Reuter Victor E.¹

Affiliation:

1. From the Departments of Surgery (Urology Service), Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Peptide-hormone and serotonin-immunoreactive tumour cells in carcinoma of the prostate;Abrahamsson;Path. Res. Pract.,1987

2. Neuroendocrine differentiation in prostatic carcinoma;di Sant’Agnese;Hum. Path.,1987

3. The endocrine component of prostatic carcinomas, mixed adenocarcinoma-carcinoid tumours and nontumour prostate. Histochemical and ultrastructural identification of the endocrine cells;Capella;Histopathology,1981

4. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an endocrine marker;Abrahamsson;Path. Res. Pract.,1989

5. Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium;Azzopardi;J. Path.,1971

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series;Histopathology;2022-07-11

2. Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer;iScience;2022-07

3. Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta‐analysis;BJU International;2021-12-05

4. Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer;Translational Oncology;2021-11

5. Neoplasms of the Prostate;Urologic Surgical Pathology;2020